Skip to main content
Clinical Trials/KCT0006018
KCT0006018
Recruiting
N/A

An exploratory clinical trial to evaluate the clinical benefit of AUC-based vancomycin TDM in Korean patients with MRSA infection

Kangwon National University Hospital0 sites80 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
Certain infectious and parasitic diseases
Sponsor
Kangwon National University Hospital
Enrollment
80
Status
Recruiting
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
5 years ago
Study Type
Observational Study
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • ? Patients who have the ability to sign the consent form in accordance with GCP and corresponding laws
  • ? Patients who are 19 years or older
  • ? Patients who were decided to administer vancomycin for 7 days or more due to MRSA infection or within 3 days after initiation of vancomycin dosing
  • ? Patient who understands the contents of the clinical research and provide their written informed consent forms

Exclusion Criteria

  • ? Patients who co\-administered vancomycin, except for the intravenous route. (e.g., per oral)
  • ? Patients with contraindications for vancomycin (e.g., Anaphylaxis due to vancomycin)
  • ? Patients in pregnancy or lactation
  • ? Patients whom the researcher deemed inappropriate for clinical research participation

Outcomes

Primary Outcomes

Not specified

Similar Trials